Headache Pharmacotherapy Flashcards

1
Q

Headache disorders

epidemiology

A

 Overall highest incidence in early adulthood
 66% of women and 57 % of men report one headache per month
 67% of people use OTC for treatment
 Prevalence of migraine increased in last 20 yrs by 60%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Common chars of primary headache disorders

Migraine/tension/cluster

Prevalence/frequency/severity

A

Migraine
Prevalence: 10-15%
Frequency: 1-4/month
Severity: Mod-severe

Tension
Prevalence: 40%
Frequency: 1-15/month
Severity: Mild-mod

Cluster
Prevalence: 0.007%
Frequency: Qday x 1-2 month
Severity: severe

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Common chars of primary headache disorders

Migraine/tension/cluster

Unilateral/duration/pain type/assoc sx

A
Migraine
Unilateral: 60%
Duration: 4-72 hours
Pain type: Throbbing
Assoc sx: Aura, n/v
Tension
Unilateral: Rarely
Duration: 15-180 minutes
Pain type: Dull
Assoc sx: Stiffness
Cluster
Unilateral: Always
Duration: Variable
Pain type: Sharp
Assoc sx: Autonomic (lacrimation, nasal stuffiness)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Chronic daily headache

A

Many pts have headache >15 day/mon and suffer from CDH which can be secondary to tension-type, migraine

Many CDH are a result of analgesic overuse (analgesic rebound headache/drug-induced headache)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Mechanisms of headache

Vascular hypothesis

A

HA due to alteration in blood flow

HA due to compensatory vasodilation

Many effective drugs dont effect bld vessels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Mechanisms of headache

Neurovascular hypothesis

A

Implicates trigeminovascular system

complex interaction between trigeminal nerve and the cranial blood vessels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Mechanisms of headache pain

Trigeminovascular system

A

trigeminovascular system is a network of nerve fibers that innervate cranial vessels
Sensitization of vessels is likely to produce headache
regulated partly by seretonin (5HT) which may decrease in acute attack (migraine?)
Calcitonin G related peptide
5HT-1D receptors on trigeminal nerve
5HT-1B receptors on cranial vessel

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Principles of headache pharmacotherapy

Acute therapy

A

Used during individual attacks to treat the intensity of pain and its associated symptoms

Treat early in the attack!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Headache pharmacotherapy

Prophylactic therapy

A

Indicated when patients have either frequent headaches or despite infrequent headaches the devastating nature makes prevention worthwhile

Attacks of headache occur at a frequency greater than 2 per week (except cluster)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Migraine therapy

Tx

A
1st line:
Triptans
NSAIDs or acetaminophen may be helpful in mild cases
Alternatives:
Ergot alkaloids
Antiemetics in combination
Opioid analgesics
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Migraine therapy

prophylaxis

A
Prophylaxis
1st line:
β-blockers or topiramate
Alternatives:
Anti-depressants
Verapamil
Valproic acid
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Tension-type therapy

Tx

A
Treatment
1st line:
NSAIDs or acetaminophen 
Alternatives:
Butalbital + caffeine
Opioid analgesics
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Tension-type therapy

prophylaxis

A

Prophylaxis
1st line:
Amitryptiline

Alternatives:
- migraine prophylaxis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Cluster type therapy

Tx

A
Treatment
1st line:
oxygen
Alternatives:
Triptans
Ergot alkaloids
Steroids
Topical anesthetics
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Cluster type therapy

prophylaxis

A

Prophylaxis
1st line:
Prednisone or verapamil or lithium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Menstrual migraine

chars

A

Migraine occurring before or during menses
Affects 26-60% of women with migraine
Occurs frequently during period in life where estrogen levels may be rapidly changing
Occurs less when estrogen is more constant
Mechanism is unknown
Serotonergic systems suppressed during late luteal phase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Menstrual migraine

tx

A

Standard therapy

“mini” prophylaxis- NSAIDS or triptans just prior to menses

Extended estrogen or low-dose estrogen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Pregnancy risk for headache medications

Simple analgesics

Risk factor/comments

A

Med:
Simple analgesics:

Acetaminophen
Aspirin
Caffeine

Risk Factor:
Acetaminophen B
Aspirin C/D
Caffeine B

Comments: Aspirin risk factor D in full dose in 3rd trimester

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Pregnancy risk for headache medications

NSAIDS

Risk factor/comments

A

Med
Risk Factor
Comments

NSAIDs
B/D
NSAIDs risk factor D if used in 3rd trimester or near delivery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Pregnancy risk for headache medications

Opioid analgesics

Risk factor/comments

A

Med
Risk Factor
Comments

Opioid analgesics
C/D
Opioid analgesics are risk factor D if used in high doses or for prolonged periods near delivery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Pregnancy risk for headache medications

Serotonin Agonists

Risk factor/comments

A

Med
Risk Factor
Comments

Serotonin agonists:

Ergot Alkaloids
Triptans

X
C

All ergot derivatives are contraindicated

22
Q

Pregnancy risk for headache medications

Antiemetics

Risk factor/comments

A

Med
Risk Factor
Comments

Antiemetics:
Metoclopramide
Prochlorperazine

B
C

None

23
Q

Medication misuse headache

Gen chars

A

Perpetuation of head pain in headache sufferers

Due to irresistible urge of pts to overuse drugs

24
Q

Medication misuse headache

Clinical features

A

Headaches occur nearly daily
headaches are refractory to treatment
pts use relief medications very frequently and in excessive quantities (more than 2-3 times/ week)
spontaneous improvement occurs when discontinuing the medications
Prolonged use of analgesics may suppress natural opioids causing heightened pain sensitivity
Most common offenders are OTC analgesics
Treatment is removal of the agent

25
Agents used for acute tx list Ergot alkaloids
```   Ergotamine tartarate (Egomar®)  Ergotamine + caffeine (Cafergot®, Wigrane®)  Available in PO, SL, PR forms  DHE 45® (Dihydroergotamine IV)  Migranal® nasal spray (DHE + caffeine) ```
26
Ergot alkaloids chars
Structurally related to amines (DA, EPI,NE) and can cause potent vasoconstriction MOA is by vasoconstriction of cranial arteries or by stimulating 5HT- 1 receptors (NON-SELECTIVE)
27
Ergot alkaloids Adverse events
Peripheral vasoconstriction is most serious adverse event Numbness/tingling in extremities Muscle pain Gangrene Nausea/vomiting occur in up to 10% of pts Use lowest dose possible Use with metoclopramide (antiemetic)
28
Ergot Alkaloids contraindications
``` Peripheral vascular disease hepatic impairment renal impairment coronary artery disease pregnancy concomitant triptan use ```
29
Triptans MOA/clinical use
Active selectively at 5HT-1B and 1D subtypes unlike ergots (less nausea) Are effective in both migraine as well as cluster headache
30
Sumatriptan Adverse effects
``` Typically well tolerated Most severe adverse events are coronary vasospasm, MI, arrhythmias, stroke “Triptan” symptoms chest tightness, tingling, numbness neurologic- drowsiness, lethargy ```
31
See if you need to know the chars of the various triptans
Pg. 427
32
Triptans Contraindications
PVD uncontrolled HTN coronary artery disease or significant cardiovascular disease concomitant MAO-A inhibitor within 2 weeks Except Almotriptan concomitant ergot use within 24hrs significant hepatic disease
33
Headache therapies Agents used for acute tx acetaminophen
Safest of all treatments Used in combination therapies (Midrin®) Major concern is rebound in combinations
34
Headache therapies Agents used for acute tx NSAIDs/ASA
Wide margin of safety Mech of action due to inhibition of prostaglandins as well as possible central mechanisms Commonly used in combinations GI bleeding and rebound are major concerns
35
Headache therapies Agents used for acute tx Caffeine
Wide margin of safety Mech of action probably due to vasoconstriction properties Used in combinations (Excedrin®) Side effects related to stimulant properties  elevated mood, insomnia, palpitations, diuresis Major concern is rebound in combinations
36
“Caffeinism”
Average caffeine intake 220-240mg/day Withdrawal syndrome characterized by yawning, decreased concentration and headache Headache occurs 18-24hrs after withdrawal Most effective therapy is reintroduction. May try taper of 5oz every week
37
Headache therapies Agents used for acute tx Isometheptene combination
Midrin (isometheptene + dichloralphenazone + acetaminophen) Isometheptene resembles epinephrine Dichloralphenazone is a sedative Side effects are numbness/dizziness
38
Headache therapies Agents used for acute tx Dopamine antagonists
Metoclopramide - drug of choice for nausea in migraine often given in combination to increase gut motility Prochlorperazine Chlorpromazine
39
Headache therapies Agents used for acute tx Opioid analgesics
IV MSO4, butorphanol, codeine combinations Role in migraine controversial have few effects on fundamental pathogenesis habituation/ rebound headaches
40
Headache therapies Agents used for acute prophylaxis list
``` TCA Beta-blockers Verapamil Valproic acid Topiramate Lithium Botulinum toxin ```
41
Headache therapies Agents used for acute prophylaxis TCA
Tricyclics like amitryptyline (Elavil®) are drugs of choice for tension- type prophylaxis and are also effective in migraine prophylaxis Most common side effects are ANTICHOLINERGIC in nature Do not use in pregnant women, glaucoma, urinary retention, with MAO-I
42
Headache therapies Agents used for acute prophylaxis Beta blockers
Generally, treatment of choice for prevention of migraines Propranalol, atenolol, metoprolol effective MOA unknown; may raise migraine threshold Side effects include fatigue, hypotension, bradycardia. Caution in asthma, diabetes
43
Headache therapies Agents used for acute prophylaxis verapamil
CA channel blocker of choice for prevention of both cluster and migraine headaches Affects may take 3-8wks (limiting factor) Side effects include hypotension, edema, constipation
44
Headache therapies Agents used for acute prophylaxis Valproic acid
o MOA unknown, but has been effective in both migraine and cluster headache o Numerous side effects (n/v, weight gain, hepatotoxicity) o Consider for pts unresponsive to other agents or with a history of bipolar or seizure disorder
45
Headache therapies Agents used for acute prophylaxis Topirimate
FDA approved for migraine prophylaxis o Effective at 100-200mg/day Several patients dropped out of studies due to adverse events. Cognitive (confusion, slowed speech,memory). Weight loss
46
Headache therapies Agents used for acute prophylaxis Lithium
O Treatment of choice for prophylaxis of chronic cluster headache O Benefits take 1-2 weeks Enhances serotenergic neurotransmission O Can also precipitate a headache as well as lethargy and abdominal discomfort O Avoid in pregnancy, renal disease
47
Headache therapies Agents used for acute prophylaxis Botulinum toxin
O Mechanism of action unknown. May reduce release of pain mediators (substance P, glutamate) O Administered by several intradermal injections q2-3 months O Early controlled studies found no benefit for several types of headaches O More recent PREEMPT trials showed reduction in headache frequency when compared to placebo in patients with chronic migraine o Most common side effects were neck pain and muscle weakness o Botox appears to have some efficacy, however questions regarding long term safety and conflicting evidence remain
48
Headache pharmacotherapy DDI ergots
ergots with P450 3A4 inhibitors | ergots with macrolide antibiotics
49
Headache pharmacotherapy DDI Triptans
Tripatans with MAO-I (phenylzene) triptans metabolized by MAO, increase effect Triptans with ergots May cause extreme vasoconstriction
50
Headache pharmacotherapy DDI MAO-I
MAO-I and isometheptene excessive release of catecholamine MAO-I and antidepressants